BCYC — Bicycle Therapeutics plc

In 2026 Q2, 3 of the 140 tracked hedge funds reported a position in Bicycle Therapeutics plc (BCYC), worth $7.44M combined. Over the quarter 2 opened or added, 1 trimmed or exited.

Hedge fund holders, 2026 Q2

FundValuePortfolio %Change
Renaissance$6.50M0.00%+56.6%
Persistent$497.16K0.16%-2.6%
Quadrature$441.35K0.00%NEW

All stocks · Quarterly Trends · Hedge Fund Tracker

Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.